200 related articles for article (PubMed ID: 34722337)
1. The Presence of
Barroso DH; Nóbrega OT; de Araújo CN; Freire GSM; Martins SS; Rodrigues BC; Gomes CM; Sampaio RNR
Front Cell Infect Microbiol; 2021; 11():744163. PubMed ID: 34722337
[No Abstract] [Full Text] [Related]
2. Presence of parasite DNA in clinically unaffected nasal mucosa during cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Canário A; Queiroz M; Cunha G; Cavalcante T; Riesz V; Sharma R; de Noronha A; Correia T; Barral-Netto M; Barral A; Khouri R; Boaventura V
Clin Microbiol Infect; 2019 Apr; 25(4):515.e5-515.e7. PubMed ID: 30616010
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.
Galdino H; Maldaner AE; Pessoni LL; Soriani FM; Pereira LI; Pinto SA; Duarte FB; Gomes CM; Fleuri AK; Dorta ML; de Oliveira MA; Teixeira MM; Batista AC; Joosten LA; Vieira LQ; Ribeiro-Dias F
BMC Infect Dis; 2014 May; 14():249. PubMed ID: 24884781
[TBL] [Abstract][Full Text] [Related]
4. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of proteins secreted by Leishmania (Viannia) braziliensis strains associated to distinct clinical manifestations of American Tegumentary Leishmaniasis.
Rodríguez-Vega A; Losada-Barragán M; Berbert LR; Mesquita-Rodrigues C; Bombaça ACS; Menna-Barreto R; Aquino P; Carvalho PC; Padrón G; de Jesus JB; Cuervo P
J Proteomics; 2021 Feb; 232():104077. PubMed ID: 33309930
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
[TBL] [Abstract][Full Text] [Related]
7. Co-expression analysis of lncRNA and mRNA suggests a role for ncRNA-mediated regulation of host-parasite interactions in primary skin lesions of patients with American tegumentary leishmaniasis.
Almeida MC; Felix JS; Lopes MFDS; de Athayde FRF; Troiano JA; Scaramele NF; Furlan AO; Lopes FL
Acta Trop; 2023 Sep; 245():106966. PubMed ID: 37302689
[TBL] [Abstract][Full Text] [Related]
8. IL-32γ promotes the healing of murine cutaneous lesions caused by Leishmania braziliensis infection in contrast to Leishmania amazonensis.
Gomes RS; Silva MVT; Dos Santos JC; de Lima Silva LL; Batista AC; Machado JR; Teixeira MM; Dorta ML; de Oliveira MAP; Dinarello CA; Joosten LAB; Ribeiro-Dias F
Parasit Vectors; 2017 Jul; 10(1):336. PubMed ID: 28709468
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histopathologic features of canine tegumentary leishmaniasis and the molecular characterization of Leishmania braziliensis in dogs.
Lago J; Silva JA; Borja L; Fraga DBM; Schriefer A; Arruda S; Lago E; Carvalho EM; Bacellar O
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007532. PubMed ID: 31310601
[TBL] [Abstract][Full Text] [Related]
10. A Cytokine Network Balance Influences the Fate of
Paiva MB; Ribeiro-Romão RP; Resende-Vieira L; Braga-Gomes T; Oliveira MP; Saavedra AF; Silva-Couto L; Albuquerque HG; Moreira OC; Pinto EF; Da-Cruz AM; Gomes-Silva A
Front Immunol; 2021; 12():656919. PubMed ID: 34276650
[TBL] [Abstract][Full Text] [Related]
11. miR-548d-3p Alters Parasite Growth and Inflammation in
Souza MA; Ramos-Sanchez EM; Muxel SM; Lagos D; Reis LC; Pereira VRA; Brito MEF; Zampieri RA; Kaye PM; Floeter-Winter LM; Goto H
Front Cell Infect Microbiol; 2021; 11():687647. PubMed ID: 34178725
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.
Silva SC; Guimarães LH; Silva JA; Magalhães V; Medina L; Queiroz A; Machado PRL; Schriefer A
Acta Trop; 2018 Feb; 178():34-39. PubMed ID: 29042262
[TBL] [Abstract][Full Text] [Related]
13. Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis.
de Oliveira Camera P; Junger J; do Espírito Santo Silva Pires F; Mattos M; Oliveira-Neto MP; Fernandes O; Pirmez C
Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1112-7. PubMed ID: 16765391
[TBL] [Abstract][Full Text] [Related]
14. Immune Profile of the Nasal Mucosa in Patients with Cutaneous Leishmaniasis.
Gómez-Zafra MJ; Navas A; Jojoa J; Murillo J; González C; Gómez MA
Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32094254
[TBL] [Abstract][Full Text] [Related]
15. Parasitological and immunological follow-up of American tegumentary leishmaniasis patients.
Coutinho SG; Pirmez C; Da-Cruz AM
Trans R Soc Trop Med Hyg; 2002 Apr; 96 Suppl 1():S173-8. PubMed ID: 12055834
[TBL] [Abstract][Full Text] [Related]
16. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis.
Saravia NG; Valderrama L; Labrada M; Holguín AF; Navas C; Palma G; Weigle KA
J Infect Dis; 1989 Apr; 159(4):725-35. PubMed ID: 2647862
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of cutaneous and disseminated cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Paraty, Rio de Janeiro.
Vieira-Gonçalves R; Pirmez C; Jorge ME; Souza WJ; Oliveira MP; Rutowitsch MS; Da-Cruz AM
Int J Dermatol; 2008 Sep; 47(9):926-32. PubMed ID: 18937655
[TBL] [Abstract][Full Text] [Related]
18. Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis.
Costa DL; Guimarães LH; Cardoso TM; Queiroz A; Lago E; Roselino AM; Bacellar O; Carvalho EM; Silva JS
Hum Immunol; 2013 Dec; 74(12):1491-500. PubMed ID: 23993989
[TBL] [Abstract][Full Text] [Related]
19. Anti-Leishmania IgG is a marker of disseminated leishmaniasis caused by Leishmania braziliensis.
Magalhães A; Carvalho LP; Costa R; Pita MS; Cardoso TM; Machado PRL; Carvalho EM; Arruda S; Carvalho AM
Int J Infect Dis; 2021 May; 106():83-90. PubMed ID: 33578011
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric analysis of host and parasite elements in new world tegumentary leishmaniasis.
de Carvalho BC; Vital T; Osiro J; Gomes CM; Noronha E; Dallago B; Rosa AC; Carvalho JL; Hagström L; Hecht M; Nitz N
Front Cell Infect Microbiol; 2022; 12():956112. PubMed ID: 36017367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
